US Patent 9169196 4-(p-quinonyl)-2-hydroxybutanamide derivatives for treatment of mitochondrial diseases
Patent 9169196 was granted and assigned to Edison Pharmaceuticals on October, 2015 by the United States Patent and Trademark Office.
Is a
Current Assignee
Date Filed
June 21, 2013
Date of Patent
October 27, 2015
Patent Applicant
Patent Application Number
13924363
Patent Citations Received
Patent Jurisdiction
Patent Number
Patent Primary Examiner
Find more entities like US Patent 9169196 4-(p-quinonyl)-2-hydroxybutanamide derivatives for treatment of mitochondrial diseases
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
